OpenSAFELY Codelists

CTV3 Concept: `U60C.`

[X]Drugs, medicaments and biological substances causing adverse effects in therapeutic use U60.. (Current)

[X]Agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use `U60C.` (Current)

[X]Angiotensin II receptor antagonists causing adverse effects in therapeutic use XaIzK (Current)
[X]Angiotensin-converting-enzyme inhibitors causing adverse effects in therapeutic use U60C4 (Current)

[X]Adverse reaction to lisinopril

[X]Antihyperlipidaemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use U60C6 (Current)
[X]Antivaricose drugs, including sclerosing agents, causing adverse effects in therapeutic use U60C8 (Current)
[X]Calcium-channel blockers causing adverse effects in therapeutic use U60C1 (Current)

[X]Adverse reaction to amlodipine

[X]Cardiac-stimulant glycosides and drugs of similar action causing adverse effects in therapeutic use U60C0 (Current)
[X]Coronary vasodilators causing adverse effects in therapeutic use, not elsewhere classified U60C3 (Current)
[X]Lipid-lowering drug adverse reaction XaIRL (Current)
[X]Other and unspecified agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use U60Cy (Current)
[X]Other anti-dysrhythmic drugs causing adverse effects in therapeutic use, not elsewhere classified U60C2 (Current)
[X]Other antihypertensive drugs causing adverse effects in therapeutic use, not elsewhere classified U60C5 (Current)
[X]Peripheral vasodilators causing adverse effects in therapeutic use U60C7 (Current)
[X]Statin causing adverse effect in therapeutic use XaIsC (Current)